Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1993-11-30
1996-07-30
Tsang, Cecilia
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
5142342, 5142345, 544118, 544262, A61K 31505, A61K 31535, C07D41300, C07D21344
Patent
active
055411878
ABSTRACT:
Novel 6-heterocyclyl-pyrazolo[3,4-d]pyrimidin-4-ones, useful in treating cardiovascular disease, are prepared by reacting a 5-amino-1H-pyrazole-4-carboxamide with heterocyclyl-carboxaldehyde or by reacting a 5-amino-1H-pyrazole-4-carbonitrile with a heterocyclylcarboxamidine, followed by diazotization and hydrolysis of the resulting 4-amino-6-heterocyclyl-pyrazolo[3,4-d]pyrimidine.
REFERENCES:
patent: 3165520 (1965-01-01), Schmidt et al.
patent: 3211731 (1965-10-01), Schmidt et al.
patent: 3350397 (1967-10-01), Burch
patent: 3732225 (1973-05-01), Breuer et al.
patent: 4167568 (1979-04-01), Knowles
patent: 4666908 (1987-05-01), Hamilton
patent: 5075310 (1991-12-01), Coates
Hamilton et al, Journal Med. Chem. vol. 30, pp. 91-96 (1987).
Burch,--J. Med. Chem. 1968, pp. 79-83.
Miyashita et al, Heterocycles, 1990, p. 1309.
Bacon Edward R.
Lesher, deceased George Y.
Singh Baldev
DuPont Paul E.
Hake Richard A.
Sterling Winthrop Inc.
Tsang Cecilia
LandOfFree
6-heterocycyclyl pyrazolo[3,4-d]pyrimidin-4-ones and composition does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 6-heterocycyclyl pyrazolo[3,4-d]pyrimidin-4-ones and composition, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 6-heterocycyclyl pyrazolo[3,4-d]pyrimidin-4-ones and composition will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1658753